Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice.

PURPOSE To prospectively determine, by using dynamic imaging, whether a magnet placed over a specific area of the mouse brain could target systemically administered rhodamine-labeled magnetic fluid-loaded liposomes (MFLs) to that brain region. MATERIALS AND METHODS Experiments were performed with a French Ministry of Agriculture permit and regional ethics committee authorization. In seven anesthetized C57BL/6 mice, a closed cranial window was implanted above the left parieto-occipital cortex. A laser-scanning confocal fluorescence microscope (LSCFM) was used to track the intravenously injected rhodamine-labeled MFLs within this cortical area, through the cranial window. The MFLs were video monitored for 2 minutes every 15 minutes for 1 hour after injection. A magnet was placed on the cranial window implanted in four mice, while no magnet was placed in three (control) mice. After dynamic in vivo imaging, static in vivo imaging was performed with a different LSCFM. Ex vivo fluorescence histologic analysis was then performed. Paired Student t testing was used to compare the cerebral blood flow and two-dimensional flow values before and 1 hour after MFL injection. For image analysis, intergroup comparisons were performed by using an independent t test. RESULTS In vivo video monitoring through the window revealed that the rhodamine-labeled MFLs accumulated in the mouse brain microvasculature exposed to the magnet-first within superficial brain venules and then within intracerebral venules-with no significant change in blood flow (P > .05). MFLs accumulated neither in the arterioles of the mice with a magnet nor in the arterioles of the control mice. Static in vivo imaging findings confirmed the microvascular localization of the rhodamine-labeled MFLs, and histologic findings specified their accumulation on the side of the magnet only. CONCLUSION Real-time in vivo imaging of rhodamine-labeled MFLs in the mouse brain cortex revealed that these nanosystems can be magnetically targeted, through microvessels, to selected brain areas.

[1]  Florence Gazeau,et al.  Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.

[2]  Klaas Nicolay,et al.  MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  K. H. Al-Gubory,et al.  Fibered confocal fluorescence microscopy for imaging apoptotic DNA fragmentation at the single-cell level in vivo. , 2005, Experimental cell research.

[4]  P. Couvreur,et al.  Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? , 2005, International journal of pharmaceutics.

[5]  Valérie Cabuil,et al.  Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.

[6]  J. Seylaz,et al.  Long-Term in Vivo Investigation of Mouse Cerebral Microcirculation by Fluorescence Confocal Microscopy in the Area of Focal Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  C. Olbrich,et al.  Optical imaging in drug discovery and diagnostic applications. , 2005, Advanced drug delivery reviews.

[8]  R. Gonzalez,et al.  MRI in treatment of adult gliomas. , 2005, The Lancet. Oncology.

[9]  G. Storm,et al.  Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  A. Mehta,et al.  Fiber optic in vivo imaging in the mammalian nervous system , 2004, Current Opinion in Neurobiology.

[11]  D. Begley Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. , 2004, Pharmacology & therapeutics.

[12]  E. Vicaut,et al.  Fibered Confocal Fluorescence Microscopy (Cell-viZio™) Facilitates Extended Imaging in the Field of Microcirculation , 2004, Journal of Vascular Research.

[13]  U. Häfeli,et al.  Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.

[14]  A. Luciani,et al.  Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. , 2004, Radiology.

[15]  U. Bogdahn,et al.  Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma , 2004, Cancer.

[16]  H. Pardoe,et al.  A magnetic resonance imaging based method for measurement of tissue iron concentration in liver arterially embolized with ferrimagnetic particles designed for magnetic hyperthermia treatment of tumors. , 2003, Magnetic resonance imaging.

[17]  S. Lesieur,et al.  Evidence of surfactant-induced formation of transient pores in lipid bilayers by using magnetic-fluid-loaded liposomes. , 2003, Journal of the American Chemical Society.

[18]  Wolfgang Ebert,et al.  Tissue-specific MR contrast agents. , 2003, European journal of radiology.

[19]  Christoph Alexiou,et al.  Magnetic Drug Targeting—Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment , 2003 .

[20]  Y. Fukuuchi,et al.  Moment Analysis of Microflow Histogram in Focal Ischemic Lesion to Evaluate Microvascular Derangement after Small Pial Arterial Occlusion in Rats , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Florence Gazeau,et al.  Magnetophoresis and ferromagnetic resonance of magnetically labeled cells , 2002, European Biophysics Journal.

[22]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[23]  U. Bogdahn,et al.  Long‐term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin , 2001, Cancer.

[24]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[25]  C. Alexiou,et al.  Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.

[26]  I. Schiszler,et al.  New optical method for analyzing cortical blood flow heterogeneity in small animals: validation of the method. , 2000, American journal of physiology. Heart and circulatory physiology.

[27]  V. Torchilin Polymeric contrast agents for medical imaging. , 2000, Current pharmaceutical biotechnology.

[28]  J. Borredon,et al.  Dynamic In Vivo Measurement of Erythrocyte Velocity and Flow in Capillaries and of Microvessel Diameter in the Rat Brain by Confocal Laser Microscopy , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  W. Pardridge,et al.  Vector-mediated drug delivery to the brain. , 1999, Advanced drug delivery reviews.

[30]  Tilcock Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. , 1999, Advanced drug delivery reviews.

[31]  D. Letourneur,et al.  Liposomes coated with chemically modified dextran interact with human endothelial cells. , 1999, Journal of biomedical materials research.

[32]  D. Lasič Novel applications of liposomes. , 1998, Trends in biotechnology.

[33]  D. Huhn,et al.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.

[34]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[35]  N. Templeton,et al.  Liposomes in Gene Therapy , 1996, Handbook of Nonmedical Applications of Liposomes: From Gene Delivery and Diagnostics to Ecology.

[36]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[38]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[39]  N. Strachan,et al.  Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo. , 2004, Biorheology.

[40]  Alexander V Kabanov,et al.  Nanogels for oligonucleotide delivery to the brain. , 2004, Bioconjugate chemistry.

[41]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[42]  T M Allen,et al.  Long circulating liposomes: past, present and future. , 1996, Biotechnology advances.

[43]  M. Dewhirst,et al.  Polymer-Grafted Liposomes: Physical Basis for the “Stealth” Property , 1992 .